Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain
- Colomer, R
- Llombart-Cussac, A
- Lluch, A
- Barnadas, A
- Ojeda, B
- Caranana, V
- Fernandez, Y
- Garcia-Conde, J
- Alonso, S
- Montero, S
- Hornedo, J
- Guillem, V;
Annals Of Oncology (p. 201-206) - 1/1/2004
10.1093/annonc/mdh048 Ver en origen
- ISSN 09237534
Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors
- Castellano, D
- Hitt, R
- Ciruelos, E
- Cortes-Funes, H
- Colomer, R;
Annals Of Oncology (p. 783-787) - 1/5/2003
10.1093/annonc/mdg196 Ver en origen
- ISSN 09237534
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
- Porta, R.
- Sanchez-Torres, J. M.
- Paz-Ares, L.
- Massuti, B.
- Reguart, N.
- Mayo, C.
- Lianes, P.
- Queralt, C.
- Guillem, V.
- Salinas, P.
- Catot, S.
- Isla, D.
- Pradas, A.
- Gurpide, A.
- de Castro, J.
- Polo, E.
- Puig, T.
- Taron, M.
- Colomer, R.
- Rosell, R.;
European Respiratory Journal (p. 624-631) - 1/3/2011
- ISSN 09031936
- iMarina
Breast cancer survivorship symptom management: current perspective and future development
- G Van Londen
- EB Beckjord
- MA Dew
- P Cuijpers
- S Tadic
- A Brufsky
Breast Cancer Management (p. 71-81) - 1/1/2013
- iMarina
Breast-cancer adjuvant therapy with zoledronic acid
- Coleman, Robert E.
- Marshall, Helen
- Cameron, David
- Dodwell, David
- Burkinshaw, Roger
- Keane, Maccon
- Gil, Miguel
- Houston, Stephen J.
- Grieve, Robert J.
- Barrett-Lee, Peter J.
- Ritchie, Diana
- Pugh, Julia
- Gaunt, Claire
- Rea, Una
- Peterson, Jennifer
- Davies, Claire
- Hiley, Victoria
- Gregory, Walter
- Bell, Richard;AZURE Investigators
New England Journal Of Medicine (p. 188-189) - 12/1/2012
10.1056/nejmc1113049 Ver en origen
- ISSN 15334406
CA 15.3 - EARLY RESULTS OF A NEW BREAST-CANCER MARKER
- COLOMER, R
- SOLE, LA
- NAVARRO, M
- ENCABO, G
- RUIBAL, A
- SALVADOR, L;
Anticancer Research (p. 683-684) - 1/7/1986
- ISSN 02507005
- iMarina
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner
- Manes, Santos
- Mira, Emilia
- Colomer, Ramon
- Montero, Sagrario
- Real, Luis M
- Gomez-Mouton, Concepcion
- Jimenez-Baranda, Sonia
- Garzon, Alfredo
- Lacalle, Rosa Ana
- Harshman, Keith
- Ruiz, Agustin
- Martinez-A, Carlos
Journal Of Experimental Medicine (p. 1381-1389) - 3/11/2003
10.1084/jem.20030580 Ver en origen
- ISSN 00221007
CHARACTERIZATION OF A GROWTH-FACTOR THAT BINDS EXCLUSIVELY TO THE ERBB-2 RECEPTOR AND INDUCES CELLULAR-RESPONSES
- RUTH Lupu
- Ramon Colomer
- Bhanu Kannan
- Marc E Lippman
Proceedings Of The National Academy Of Sciences Of The United States Of America (p. 2287-2291) - 1/1/1992
10.1073/pnas.89.6.2287 Ver en origen
- ISSN 10916490
- iMarina
- iMarina
CIRCULATING ANTIGEN LEVELS IN OVARIAN-CANCER
- COLOMER, R
- GENOLLA, J
- DELCAMPO, JM
- RUIBAL, A;
Journal Of Clinical Oncology (p. 1148-1149) - 1/1/1986
10.1200/jco.1986.4.7.1148 Ver en origen
- ISSN 0732183X
CIRCULATING CA 15-3 LEVELS IN THE POSTSURGICAL FOLLOW-UP OF BREAST-CANCER PATIENTS AND IN NON-MALIGNANT DISEASES
Breast Cancer Research And Treatment (p. 123-133) - 1/3/1989
10.1007/bf01806524 Ver en origen
- ISSN 01676806
Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study
- J Albanell
- E Ciruelos
- R Colomer
- J De la Haba
- M Martin
- De Salas-Cansado
- B Munoz-Molina
- C Tournier
- P Thuresson
- W Schleich
1/1/2015
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Medicina de precisión en oncología: Éxitos y perspectivas bioéticas
- Ramón Colomer Bosch
Bioética Y Cáncer (p. 17-26) - 1/1/2020
- iMarina
18F-misonidazole PET (FMISO-PET) monitors vascular normalization (VN) and predicts benefit from antiangiogenic treatment plus chemotherapy in pancreas cancer
- Mondejar, Tamara
- Hernadez-Agudo, Elena
- Soto-Montenegro, Marisa
- Megias, Diego
- Cebrian, David
- Sanchez, Jesus
- Mulero, Francisca
- Colomer, Ramon
- Hidalgo, Manuel
- Desco, Manuel
- Quintela-Fandino, Miguel;
Cancer Research - 1/1/2015
10.1158/1538-7445.am2015-1493 Ver en origen
- ISSN 00085472
A decade of clinical investigation in elderly patients with non-Hodgkin's lymphoma: Results as reported in the literature
- Gomez, H
- Colomer, R
- Casttellanos, D
- CortesFunes, H;
European Journal Of Cancer (p. 1205-1205) - 1/1/1997
- ISSN 09598049
- iMarina
ADDING PERTUZUMAB IN NEOADJUVANT TREATMENT OF PATIENTS WITH HER2(+) BREAST CANCER IN SPAIN: A COST OFFSETS STUDY
- Albanell, J.
- Ciruelos, E.
- Colomer, R.
- De la Haba, J.
- Martin, M.
- De Salas-Cansado, M.
- Munoz-Molina, B.
- Tournier, C.
- Thuresson, P.
- Schleich, W.;MORSE Hlth Technology Assessment
- Global Pricing Market Access
Basic & Clinical Pharmacology & Toxicology (p. 42-42) - 1/1/2015
- ISSN 17427835
- iMarina
An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations
- B Leyland-Jones
- R Colomer
- M Trudeau
- A Wardley
- J Latreille
- D Cameron
- R Cubedo
- N Al-Sakaff
- JE Charoin
- J Cortés
European Journal Of Cancer, Supplement (p. 215-215) - 1/1/2007
10.1016/s1359-6349(07)70867-4 Ver en origen
- ISSN 13596349
- iMarina
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- Fenor De La Maza
- V Pacheco-Barcia
- J Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondéjar
- O Donnay
- B Obispo
- R Colomer
- J Sánchez-Torres
Journal Of Thoracic Oncology (p. S2107-S2108) - 1/1/2017
- ISSN 15560864
- iMarina
Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
- Rogado Revuelta, Jacobo
- Romero-Laorden, Nuria
- Sanchez Torres, Jose Miguel
- Pacheco-Barcia, Vilma
- Ballesteros, Anabel
- Maria Ramos-Levi, Ana
- Arranz, Reyes
- Lorenzo, Alicia
- Gullon, Pedro
- Garrido Garcia, Ana
- Maria Serra, Jose
- Donnay, Olga
- Adrados, Magdalena
- Costas, Pablo
- Aspa, Javier
- Alfranca, Arantza
- Fenor De la Maza, Maria Dolores
- Mondejar, Rebeca
- Colomer, Ramon;
Journal Of Clinical Oncology - 1/1/2019
- ISSN 0732183X
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with metastatic breast cancer receiving chemotherapy
- Marangolo, M.
- Lang, I.
- Beato, C.
- Colomer, R.
- Ukarma, L.;
European Journal Of Cancer, Supplement (p. 388-388) - 1/1/2005
- ISSN 13596349
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …
- M Marangolo
- I Lang
- C Beato
- R Colomer
- L Ukarma
(p. 388-388) - 1/1/2005
- iMarina
CA 15.3 - A NEW MARKER FOR BREAST-CANCER (BC) PRELIMINARY-RESULTS
- SOLE, LA
- COLOMER, R
- NAVARRO, M
- ENCABO, G
- RUIBAL, A;
Anticancer Research (p. 601-602) - 1/1/1985
- ISSN 02507005
- iMarina
CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN
- Ciruelos, E.
- Alba, E.
- Lopez, R.
- Lluch, A.
- Martin, M.
- Arroyo, I
- Navarro, B.
- Carcedo, D.
- Colomer, R.
- Albanell, J.;
Value In Health (p. S18-S18) - 1/1/2018
10.1016/j.jval.2018.09.102 Ver en origen
- ISSN 10983015
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id